Sánchez-Herrero, E., Serna-Blasco, R., Ivanchuk, V., García-Campelo, R., Dómine Gómez, M., Sánchez, J. M., . . . Romero, A. (2021). NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: A step toward personalized NSCLC treatment.
Citación estilo ChicagoSánchez-Herrero, Estela, et al. NGS-based Liquid Biopsy Profiling Identifies Mechanisms of Resistance to ALK Inhibitors: A Step Toward Personalized NSCLC Treatment. 2021.
Cita MLASánchez-Herrero, Estela, et al. NGS-based Liquid Biopsy Profiling Identifies Mechanisms of Resistance to ALK Inhibitors: A Step Toward Personalized NSCLC Treatment. 2021.
Precaución: Estas citas no son 100% exactas.